维普期刊资源整合服务平台（V6.5）

75篇 您的检索式：作者名="Seto WK"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	血清HBV RNA和HBsAg水平在判断亚洲慢性乙型肝炎患者是否适合停用恩替卡韦中的作用显示文摘【据Gut 2020年8月报道】题:血清HBV RNA和HBsAg水平在判断亚洲慢性乙型肝炎患者是否适合停用恩替卡韦中的作用(作者Seto WK等)来自中国香港的Seto等研究显示,在HBsAg血清清除前,慢性HBV感染的某些亚群患者可能已经停止治疗了。血清HBV RNA在决定停止治疗适宜性方面的作用中尚未得到很好的研究。	SETO WK LIU KS MAK LY 徐晓桐金晶兰	2020	临床肝胆病杂志2020，36，11：	7
2	Reduction of hepatitis B sur-face antigen and covalently closed circular DNA by nucleos(t)ide analogues of different potency显示文摘	Wong DK Seto WK Fung J		0，，8：	1
3	Nucleoside/nucleotide analogues in the treatment of chronic hepatitis B显示文摘	Fung J Lai CL Seto WK	2011	J Antimicrob Chemother2011，66，12：	1
4	Evidence of serologic activity in chronic hepatitis B after surface antigen (HBsAg) seroclearance documented by conventional HBsAg assay显示文摘	Seto WK Tanaka Y Wong DK		0，，1：	1
5	Significance of HBV DNA levels at 12 weeks of telbivudine treatment and the 3 years treatment outcome 显示文摘	Seto WK Lai CL Fung J	2011	J Hepatol2011，55，3：	1
6	Current antiviral therapy of chronic hepatitis B: efficacy and safety显示文摘	Lam YF Yuen MF Seto WK	2011	Curt Hepat Rep2011，10，4：	1
7	Long-term lamivudine therapy reduces the risk of long-term complications of chronic hepatitis B infection even in patients without advanced disease 显示文摘	Yuen MF Seto WK Chow DH	2007	Antivir Ther2007，12，8：	1
8	Long-term lamivudine therapy reduces the risk of long-term complications of chronic hepatitis B infec- tion even in patients without advanced disease显示文摘	Yuen MF Seto WK Chow DHF	2007	Antivir Ther2007，12，：	1
9	Profile of HBV DNA in a large population of Chinese patients with chronic hepatitis B:implications for antiviral therapy显示文摘	Fung J Seto WK Lai CL	2011	J Hepatol2011，54，2：	1
10	Nucleic Acid testing for the detection of HBV DNA显示文摘	Seto WK Lai CL Yuen MF	2011	Hepat Mon2011，11，10：	1
11	Current antiviral ther- apy of chronic hepatitis B:Efficacy and safety显示文摘	Lam YF Yuen ME Seto WK	2011	Curt Hepat Rep2011，10，4：	1
12	Natural history of chronic hepatitis C: genotype 1 versus genotype 6显示文摘	Seto WK Lai CL Fung J	2010	J Hepatol2010，53，3：	1
13	Epidemiology of hepatocellularcarcinoma in the Asia-Pacific Region显示文摘	Zhu RX Seto WK Lai CL	2016	Gut Liver2016，10，：	1
14	High hepatitis B surface antigen levels predict insignificant fibrosis in hepatitis B e antigen positive chronic hepatitis B 显示文摘	Seto WK Wong DK Fung J	2012	PLoS One2012，7，43：	1
15	Reduction of hepatitis B surface antigen and covalently closed circular DNA by nucleos( t ) ide analogues of different potency 显示文摘	Wong DK Seto WK Fung J	2013	Clin Gastroenterol Hepatol2013，11，8：	1
16	Three years of continuous ente- cavir therapy in treatment-naive chronic hepatitis B patients:VI- RAL suppression,viral resistance,end clinical safety 显示文摘	Yuen MF Seto WK Fung J	2011	Am J Gastroenierol2011，106，：	1
17	Three years of continuous ente- cavir therapy in treatment-halve chronic hepatitis B patients:viral suppression, viral resistance and clinical safety 显示文摘	Yuen MF Seto WK Fung J	2011	Am J Gastroen- terol2011，106，7：	1
18	High hepatitis B surface antigen levels predict insignificant fibrosis in hepatitis B e antigen positive chronic hepatitis B 显示文摘	Seto WK Wong DKH Fung J	2012	PLoS one2012，7，43：	1
19	Three years of continu- ous entecavir therapy in treatment-naive chronic hepatitis B patients : VIRAL suppression, viral resistance, and clini- cal safety显示文摘	Yuen MF Seto WK Fung J	2011	Am J Gastroenterol2011，106，7：	1
20	Natural history of chronic hepatitis C: genotype 1 versus genotype 6显示文摘	Seto WK Lai CL Fung J	2010	J Hepatol2010，53，：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示